Checkmark2
Designed for Multi-Organ Fibrosis
We focus on shared pathways that drive fibrosis across lung, skin, and urological systems.
Focused Execution Through Thenduro
Our first subsidiary, Thenduro, applies Thendor’s peptide discovery engine to urological fibrosis, demonstrating our ability to create specialized teams that drive targeted scientific progress in urological fibrosis.
Working Together for Impact
We partner with collaborators, clinicians, and scientific advisors to advance fibrosis research that may inform the development of meaningful therapies.